Loading...
Intensity Therapeutics, Inc.
INTS•NASDAQ
Healthcare
Biotechnology
$0.28
$-0.04(-13.17%)
Intensity Therapeutics, Inc. (INTS) Financial Performance & Statements
Review Intensity Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-99.36%
↓ 99.36%
Net Income Growth
-54.37%
↓ 54.37%
Operating Cash Flow Growth
-111.24%
↓ 111.24%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-527.85%
↓ 527.85%
ROIC
-3494.50%
↓ 3494.50%
Intensity Therapeutics, Inc. (INTS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Intensity Therapeutics, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $6000.00 | $6000.00 |
| Gross Profit | $0.00 | $0.00 | -$6000.00 | -$6000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $1.97M | $2.15M | $3.56M | $2.81M |
| SG&A Expenses | $1.24M | $1.42M | $1.51M | $1.92M |
| Operating Expenses | $3.20M | $3.57M | $5.07M | $4.74M |
| Total Costs & Expenses | $3.20M | $3.57M | $5.07M | $4.74M |
| Interest Income | $28000.00 | $48000.00 | $98000.00 | $140000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $6000.00 | $57000.00 | $6000.00 | $6000.00 |
| EBITDA | -$3.17M | -$3.51M | -$4.96M | -$4.60M |
| EBITDA Ratio | ||||
| Operating Income | -$3.20M | -$3.57M | -$5.07M | -$4.74M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $22000.00 | $57000.00 | $98000.00 | $140000.00 |
| Income Before Tax | -$3.18M | -$3.51M | -$4.97M | -$4.60M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$37276.00 |
| Net Income | -$3.18M | -$3.51M | -$4.97M | -$4.60M |
| Net Income Ratio | ||||
| EPS | -$0.23 | -$0.25 | -$0.36 | -$0.34 |
| Diluted EPS | -$0.23 | -$0.25 | -$0.36 | -$0.34 |
| Weighted Avg Shares Outstanding | $14.63M | $13.80M | $13.71M | $13.71M |
| Weighted Avg Shares Outstanding (Diluted) | $14.63M | $13.80M | $13.71M | $13.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan